Wells Fargo & Company Immunic, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Immunic, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 197 shares of IMUX stock, worth $212. This represents 0.0% of its overall portfolio holdings.

Number of Shares

197

Previous 447 55.93%

Holding current value

$212

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.08 - $1.95 $270 - $487	-250 Reduced 55.93%	197 $0
Q2 2024 Aug 13, 2024	SELL	$0.98 - $1.44 $520 - $764	-531 Reduced 54.29%	447 $0
Q1 2024 May 10, 2024	BUY	$1.14 - $1.53 $441 - $592	387 Added 65.48%	978 $1,000
Q4 2023 Feb 09, 2024	BUY	$0.97 - $1.6 $16 - $27	17 Added 2.96%	591 $0
Q3 2023 Nov 13, 2023	BUY	$1.35 - $2.87 $87 - $186	65 Added 12.77%	574 $0
Q2 2023 Aug 15, 2023	BUY	$1.33 - $2.51 $14 - $27	11 Added 2.21%	509 $1,000
Q1 2023 May 12, 2023	BUY	$1.35 - $2.87 $41 - $88	31 Added 6.64%	498 $0
Q4 2022 Feb 13, 2023	BUY	$1.13 - $10.8 $59 - $572	53 Added 12.8%	467 $0
Q3 2022 Nov 14, 2022	SELL	$3.0 - $5.49 $159 - $290	-53 Reduced 11.35%	414 $2,000
Q2 2022 Aug 12, 2022	SELL	$3.13 - $12.25 $3,292 - $12,887	-1,052 Reduced 69.26%	467 $2,000
Q1 2022 May 16, 2022	SELL	$9.54 - $14.26 $64,442 - $96,326	-6,755 Reduced 81.64%	1,519 $17,000
Q4 2021 Feb 14, 2022	BUY	$7.34 - $10.25 $58,837 - $82,164	8,016 Added 3106.98%	8,274 $79,000
Q3 2021 Nov 15, 2021	SELL	$8.05 - $13.29 $209 - $345	-26 Reduced 9.15%	258 $2,000
Q2 2021 Aug 16, 2021	SELL	$11.76 - $16.85 $4,633 - $6,638	-394 Reduced 58.11%	284 $3,000
Q1 2021 May 13, 2021	SELL	$14.21 - $25.3 $357,665 - $636,801	-25,170 Reduced 97.38%	678 $10,000
Q4 2020 Feb 09, 2021	BUY	$14.8 - $20.37 $87,394 - $120,284	5,905 Added 29.61%	25,848 $395,000
Q3 2020 Nov 05, 2020	BUY	$11.74 - $22.0 $24,313 - $45,562	2,071 Added 11.59%	19,943 $371,000
Q2 2020 Aug 13, 2020	BUY	$5.67 - $15.86 $40,018 - $111,939	7,058 Added 65.27%	17,872 $216,000
Q1 2020 May 14, 2020	BUY	$4.22 - $9.8 $45,635 - $105,977	10,814 New	10,814 $65,000

Others Institutions Holding IMUX

# of Institutions

Shares Held

56.2M

Call Options Held

100

Put Options Held

350K

View Full List

About IMMUNIC, INC.

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $33M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

More about IMUX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Immunic, Inc. Transaction History